|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McCracken M, Olsen M, Chen MS Jr, Jemal A,
Thun M, Cokkinides V, Deapen D and Ward E: Cancer incidence,
mortality, and associated risk factors among asian americans of
chinese, filipino, vietnamese, korean, and Japanese ethnicities. CA
Cancer J Clin. 57:190–205. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sarela AI: Systematic review of genetic
influences on the prognosis of colorectal cancer (Br J Surg 2004;
91: 1275–1291). Brit J Surg. 91:1275–1291. 2004. View Article : Google Scholar
|
|
4
|
Duffy MJ, van Dalen A, Haglund C, Hansson
L, Klapdor R, Lamerz R, Nilsson O, Sturgeon C and Topolcan O:
Clinical utility of biochemical markers in colorectal cancer:
European Group on Tumor Markers (EGTM) guidelines. Eur J Cancer.
39:718–727. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thomas SN, Tong Z, Stebe KJ and
Konstantopoulos K: Identification, characterization and utilization
of tumor cell selectin ligands in the design of colon cancer
diagnostics. Biorheology. 46:207–225. 2009.
|
|
6
|
Hammarström S: The carcinoembryonic
antigen (CEA) family: Structures, suggested functions and
expression in normal and malignant tissues. Semin Cancer Biol.
9:67–81. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Borgoño CA, Michael IP and Diamandis EP:
Human tissue kallikreins: Physiologic roles and applications in
cancer. Mol Cancer Res. 2:257–280. 2004.PubMed/NCBI
|
|
8
|
Yousef GM and Diamandis EP: The new
kallikrein-like gene, KLK-L2. Molecular characterization, mapping,
tissue expression, and hormonal regulation. J Biol Chem.
274:37511–37516. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brattsand M and Egelrud T: Purification,
molecular cloning, and expression of a human stratum corneum
trypsin-like serine protease with possible function in
desquamation. J Biol Chem. 274:30033–30040. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Michael IP, Pampalakis G, Mikolajczyk SD,
Malm J, Sotiropoulou G and Diamandis EP: Human tissue kallikrein 5
is a member of a proteolytic cascade pathway involved in seminal
clot liquefaction and potentially in prostate cancer progression. J
Biol Chem. 281:12743–12750. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Michael IP, Sotiropoulou G, Pampalakis G,
Magklara A, Ghosh M, Wasney G and Diamandis EP: Biochemical and
enzymatic characterization of human kallikrein 5 (hK5), a novel
serine protease potentially involved in cancer progression. J Biol
Chem. 280:14628–14635. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ohler A, Debela M, Wagner S, Magdolen V
and Becker-Pauly C: Analyzing the protease web in skin: Meprin
metalloproteases are activated specifically by KLK4, 5 and 8 vice
versa leading to processing of proKLK7 thereby triggering its
activation. Biol Chem. 391:455–460. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Diamandis EP and Yousef GM: Human tissue
kallikreins: A family of new cancer biomarkers. Clin Chem.
48:1198–1205. 2002.PubMed/NCBI
|
|
14
|
Kim H, Scorilas A, Katsaros D, Yousef GM,
Massobrio M, Fracchioli S, Piccinno R, Gordini G and Diamandis EP:
Human kallikrein gene 5 (KLK5) expression is an indicator of poor
prognosis in ovarian cancer. Br J Cancer. 84:643–650. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yousef GM, Scorilas A, Kyriakopoulou LG,
Rendl L, Diamandis M, Ponzone R, Biglia N, Giai M, Roagna R,
Sismondi P and Diamandis EP: Human kallikrein gene 5 (KLK5)
expression by quantitative PCR: An independent indicator of poor
prognosis in breast cancer. Clin Chem. 48:1241–1250.
2002.PubMed/NCBI
|
|
16
|
Avgeris M, Papachristopoulou G,
Polychronis A and Scorilas A: Down-regulation of kallikrein-related
peptidase 5 (KLK5) expression in breast cancer patients: A
biomarker for the differential diagnosis of breast lesions. Clin
Proteomics. 8:52011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yousef GM, Obiezu CV, Jung K, Stephan C,
Scorilas A and Diamandis EP: Differetial expression of kallikrein
gene 5 in cancerous and normal testicular tissues. Urology.
60:714–718. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yousef GM, Polymeris ME, Grass L,
Soosaipillai A, Chan PC, Scorilas A, Borgoño C, Harbeck N,
Schmalfeldt B, Dorn J, et al: Human kallikrein 5: A potential novel
serum biomarker for breast and ovarian cancer. Cancer Res.
63:3958–3965. 2003.PubMed/NCBI
|
|
19
|
Korbakis D, Gregorakis AK and Scorilas A:
Quantitative analysis of human kallikrein 5 (KLK5) expression in
prostate needle biopsies: An independent cancer biomarker. Clin
Chem. 55:904–913. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sotiropoulou G, Pampalakis G and Diamandis
EP: Functional roles of human kallikrein-related peptidases. J Biol
Chem. 284:32989–32994. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Talieri M, Li L, Zheng Y, Alexopoulou DK,
Soosaipillai A, Scorilas A, Xynopoulos D and Diamandis EP: The use
of kallikrein-related peptidases as adjuvant prognostic markers in
colorectal cancer. Br J Cancer. 100:1659–1665. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu Y, Liu X, Chen Y and Hu C: Development
and evaluation of an ELISA method for the measurement of
kallikrein-related peptidase 5 (KLK5) in human serum. Open J Clin
Diagn. 3:159–166. 2013. View Article : Google Scholar
|
|
23
|
Fan X, Liu B, Xu H, Yu B, Shi S, Zhang J,
Wang X, Wang J, Lu Z, Ma H and Zhou X: Immunostaining with EGFR
mutation-specific antibodies: a reliable screening method for lung
adenocarcinomas harboring EGFR mutation in biopsy and resection
samples. Human Pathology. 44:1499–1507. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Anthony T, Simmang C, Hyman N, Buie D, Kim
D, Cataldo P, Orsay C, Church J, Otchy D, Cohen J, et al Standards
Practice Task Force, The American Society of Colon and Rectal
Surgeons: Practice parameters for the surveillance and follow-up of
patients with colon and rectal cancer. Dis Colon Rectum.
47:807–817. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Avgeris M, Mavridis K and Scorilas A:
Kallikrein-related peptidase genes as promising biomarkers for
prognosis and monitoring of human malignancies. Biol Chem.
391:505–511. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mavridis K and Scorilas A: Prognostic
value and biological role of the kallikrein-related peptidases in
human malignancies. Future Oncol. 6:269–285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Diamandis EP, Borgoño CA, Scorilas A,
Yousef GM, Harbeck N, Dorn J, Schmalfeldt B and Schmitt M:
Immunofluorometric quantification of human kallikrein 5 expression
in ovarian cancer cytosols and its association with unfavorable
patient prognosis. Tumour Biol. 24:299–309. 2003. View Article : Google Scholar
|
|
28
|
Kurlender L, Yousef GM, Memari N, Robb JD,
Michael IP, Borgoño C, Katsaros D, Stephan C, Jung K and Diamandis
EP: Differential expression of a human kallikrein 5 (KLK5) splice
variant in ovarian and prostate cancer. Tumor Biol. 25:149–156.
2004. View Article : Google Scholar
|
|
29
|
Kim JT, Song EY, Chung KS, Kang MA, Kim
JW, Kim SJ, Yeom YI, Kim JH, Kim KH and Lee HG: Up-regulation and
clinical significance of serine protease kallikrein 6 in colon
cancer. Cancer. 117:2608–2619. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Talieri M, Alexopoulou DK, Scorilas A,
Kypraios D, Arnogiannaki N, Devetzi M, Patsavela M and Xynopoulos
D: Expression analysis and clinical evaluation of
kallikrein-related peptidase 10 (KLK10) in colorectal cancer. Tumor
Biol. 32:737–744. 2011. View Article : Google Scholar
|
|
31
|
White NM, Bui A, Mejia-Guerrero S, Chao J,
Soosaipillai A, Youssef Y, Mankaruos M, Honey RJ, Stewart R, Pace
KT, et al: Dysregulation of kallikrein-related peptidases in renal
cell carcinoma: Potential targets of miRNAs. Biol Chem.
391:411–423. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
White NM, Chow TF, Mejia-Guerrero S,
Diamandis M, Rofael Y, Faragalla H, Mankaruous M, Gabril M, Girgis
A and Yousef GM: Three dysregulated miRNAs control kallikrein 10
expression and cell proliferation in ovarian cancer. Br J Cancer.
102:1244–1253. 2010. View Article : Google Scholar : PubMed/NCBI
|
